OpenVSafe by OpenVAERS
Search V-safe

6YY-32092-02458

3 vaccinations 14 coded responses 38 check-ins 13 free-text entries 3 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
960 / CA
Registered
2021-03-28
Relationship
Self
Race
N/A
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-28
    Registered in v-safe
  2. 2021-04-09
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-09
    Survey response — day 0, dose 1
    MedDRA: Parosmia — Feeling: Good · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea
    Free text: Phantom odors (fruity)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-04-10
    Survey response — days 1–6 daily, dose 1
    MedDRA: Disturbance in attention, Rhinorrhoea, Secretion discharge — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Runny nose/mucus production, lack of concentration
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tiredness, Nausea, Diarrhea
    Adult check-in
  6. 2021-04-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Diarrhea
    Adult check-in
  8. 2021-04-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  9. 2021-04-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-16
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-04-23
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-30
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-30
    Survey response — day 0, dose 2
    MedDRA: Injection site haemorrhage — Feeling: Good · Site: Pain, Swelling · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Bleeding from injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-05-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Hyperhidrosis, Injection site bruising — Feeling: Good · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Free text: Small bruise at injection site, moderate overall sweating
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-05-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  16. 2021-05-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Contusion — Feeling: Good · Site: Pain, Swelling · Fatigue or tiredness
    Free text: Insect bite, bruise not at injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-05-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-05-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-05-07
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-05-14
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-21
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-30
    Survey response — day 28, dose 2
    MedDRA: Abdominal discomfort, Constipation, Diarrhoea, Dyspepsia, Flatulence, Nausea — Feeling: Good
    Free text: Moderate GI upset (approx. 3 day duration) - Indigestion, nausea, painful gas (upper & lower), + minor constipation & minor diarrhea.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-06-04
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-06-11
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-08-01
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-10-29
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2022-01-04
    Dose 3 — Pfizer-BioNTech
  28. 2022-01-05
    Survey response — days 1–6 daily, dose 3
    MedDRA: Injection site hypersensitivity, Insomnia, Lymphadenopathy, Musculoskeletal pain, Sunburn, Swelling, Tonsillar hypertrophy — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Moderate increased sensitivity near injection site - similar to a sunburn. Mild - Swollen lymph nodes/tonsils in neck/jaw, only on injection side. Mild- Pain and swelling in scapula area. Moderate - Insomnia.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-01-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  30. 2022-01-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Joint pains
    Adult check-in
  31. 2022-01-08
    Survey response — days 1–6 daily, dose 3
    MedDRA: Oral candidiasis — Feeling: Fair
    Free text: Thrush-like symptoms in upper mouth.
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-01-09
    Survey response — days 1–6 daily, dose 3
    MedDRA: Oral candidiasis — Feeling: Good · Site: Pain
    Free text: Mild thrush-like symptoms in upper mouth (less than yesterday)
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-01-10
    Survey response — days 1–6 daily, dose 3
    MedDRA: Nasal congestion — Feeling: Good
    Free text: Mild stuffy nose (resolved)
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-01-11
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2022-01-18
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  36. 2022-01-27
    Survey response — day 21, dose 3
    MedDRA: Cough, Pre-existing disease, Respiratory tract congestion, Sneezing — Feeling: Good
    Free text: Seasonal allergies - minor coughing, major sneezing, & mild congestion. Triggered immediately by mowing yard. No fever. Resolved w/o meds within a couple of hours, after allergen removed (shower).
    MedDRA releases: 2024-11 · check-in free text available
  37. 2022-02-01
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  38. 2022-02-08
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  39. 2022-02-17
    Survey response — day 42, dose 3
    MedDRA: Central sleep apnoea syndrome, Glycosylated haemoglobin increased, Nasal congestion, Office visit, Pre-existing disease, Therapeutic response unexpected — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Minor/moderate nasal congestion (seasonal allergies). Central sleep apnea diagnosis reduced from severe to mild-transitional (falling asleep) due to second opinion. Slight increase in A1c. · Healthcare visit (other): Standard doctor's visit.
    MedDRA releases: 2024-11 · check-in free text available
  40. 2022-02-17
    Report sent to call center — day 42, dose 3
    Get care from a doctor or other healthcare professional
    1 call case(s)
  41. 2022-02-22
  42. 2022-04-07
    Survey response — 3 months, dose 3
    MedDRA: Mass, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Lump on head (non-injury goose egg, cause to be determined). · Healthcare visit (other): Referral to ultrasound/imaging clinic
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-04-07
    Report sent to call center — 3 months, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  44. 2022-04-11
  45. 2022-07-06
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  46. 2023-01-04
    Survey response — 12 months, dose 3
    MedDRA: Blood thyroid stimulating hormone increased, COVID-19, Gastrointestinal disorder, Self-medication, Unevaluable event, Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  47. 2023-01-04
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  48. 2023-01-05
  49. 2023-01-05
  50. 2023-01-05

Vaccinations

DoseDateManufacturerCo-administered
12021-04-09Pfizer-BioNTech
22021-04-30Pfizer-BioNTech
32022-01-04Pfizer-BioNTech No

Call center

3 call center cases

3 unsuccessful

See the call center timeline

Free text

Release 7 — day 0, dose 1

2021-04-09

Systemic reaction (other): Phantom odors (fruity)

Release 7 — days 1–6 daily, dose 1

2021-04-10

Systemic reaction (other): Runny nose/mucus production, lack of concentration

Release 8 — day 0, dose 2

2021-04-30

Systemic reaction (other): Bleeding from injection site

Release 8 — days 1–6 daily, dose 2

2021-05-01

Systemic reaction (other): Small bruise at injection site, moderate overall sweating

2021-05-03

Systemic reaction (other): Insect bite, bruise not at injection site

Release 8 — day 28, dose 2

2021-05-30

Symptoms: Moderate GI upset (approx. 3 day duration) - Indigestion, nausea, painful gas (upper & lower), + minor constipation & minor diarrhea.

Release 10 — days 1–6 daily, dose 3

2022-01-05

Systemic reaction (other): Moderate increased sensitivity near injection site - similar to a sunburn. Mild - Swollen lymph nodes/tonsils in neck/jaw, only on injection side. Mild- Pain and swelling in scapula area. Moderate - Insomnia.

2022-01-08

Systemic reaction (other): Thrush-like symptoms in upper mouth.

2022-01-09

Systemic reaction (other): Mild thrush-like symptoms in upper mouth (less than yesterday)

2022-01-10

Systemic reaction (other): Mild stuffy nose (resolved)

Release 11 — day 21, dose 3

2022-01-27

Symptoms: Seasonal allergies - minor coughing, major sneezing, & mild congestion. Triggered immediately by mowing yard. No fever. Resolved w/o meds within a couple of hours, after allergen removed (shower).

Release 11 — day 42, dose 3

2022-02-17

Symptoms: Minor/moderate nasal congestion (seasonal allergies). Central sleep apnea diagnosis reduced from severe to mild-transitional (falling asleep) due to second opinion. Slight increase in A1c.
Healthcare visit (other): Standard doctor's visit.

Release 11 — 3 months, dose 3

2022-04-07

Symptoms: Lump on head (non-injury goose egg, cause to be determined).
Healthcare visit (other): Referral to ultrasound/imaging clinic

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
HCVOUnevaluable event · · ✓
SDAbdominal discomfort ✓ ✓ ✓
SDBlood thyroid stimulating hormone increased · · ✓
SDCentral sleep apnoea syndrome · · ✓
SDConstipation ✓ ✓ ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDDiarrhoea ✓ ✓ ✓
SDDyspepsia ✓ ✓ ✓
SDFlatulence ✓ ✓ ✓
SDGastrointestinal disorder · · ✓
SDGlycosylated haemoglobin increased · · ✓
SDMass · · ✓
SDNasal congestion · · ✓
SDNausea ✓ ✓ ✓
SDPre-existing disease · · ✓
SDRespiratory tract congestion · · ✓
SDSelf-medication · · ✓
SDSneezing · · ✓
SDTherapeutic response unexpected · · ✓
SDUpper respiratory tract infection · · ✓
SROContusion ✓ ✓ ✓
SRODisturbance in attention ✓ ✓ ✓
SROHyperhidrosis ✓ ✓ ✓
SROInjection site bruising ✓ ✓ ✓
SROInjection site haemorrhage ✓ ✓ ✓
SROInjection site hypersensitivity · · ✓
SROInsomnia · · ✓
SROLymphadenopathy · · ✓
SROMusculoskeletal pain · · ✓
SRONasal congestion · · ✓
SROOral candidiasis · · ✓
SROParosmia ✓ ✓ ✓
SRORhinorrhoea ✓ ✓ ✓
SROSecretion discharge ✓ ✓ ✓
SROSunburn · · ✓
SROSwelling · · ✓
SROTonsillar hypertrophy · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release